跳至主要内容
临床试验/JPRN-UMIN000012585
JPRN-UMIN000012585已完成1 期

Safety of dietary supplements including n-3 PUFA (Imark S®) for the maintenance of remission in patients with Crohn's disease: A pilot study. - Safety of dietary supplements including n-3 PUFA for CD.

Osaka University Graduate School Department of Complementary and Alternative Medicine0 个研究点目标入组 5 人开始时间: 2014年1月10日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with the following diseases. (cirrhosis, chronic renal failure, diabetes with insulin therapy and so on) 2) Patients with steroid treatment 3) Patients with anti-TNF agents treatment 4) Patients with food allergy 5) Patients less than 20 years old. 6) Patients with xerosis cutis and impossible to measure body composition 7) Patients judged to be inappropriate for this study from the doctor in charge.

研究者

发起方
Osaka University Graduate School Department of Complementary and Alternative Medicine

相似试验